DVAX today submtd Marketing Authorization to EU# Stock
s*i
1 楼
http://www.pipelinereview.com/index.php/2012072448524/Vaccines/
BERKELEY, CA, USA I July 24, 2012
DVAX submitted a Marketing Authorization Application (MAA) to the European
Medicines Agency (EMA) pursuing an indication for immunization against
infection caused by all known subtypes of hepatitis B virus in adults 18
through 70 years of age and in patients with chronic kidney disease.
BERKELEY, CA, USA I July 24, 2012
DVAX submitted a Marketing Authorization Application (MAA) to the European
Medicines Agency (EMA) pursuing an indication for immunization against
infection caused by all known subtypes of hepatitis B virus in adults 18
through 70 years of age and in patients with chronic kidney disease.